Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trial.

Haas DW, Fessel WJ, Delapenha RA, Kessler H, Seekins D, Kaplan M, Ruiz NM, Ploughman LM, Labriola DF, Manion DJ
J Infect Dis. 2001 183 (3): 392-400

PMID: 11133370 · DOI:10.1086/318083

MeSH Terms (19)

Adult Alkynes Anti-HIV Agents Benzoxazines CD4 Lymphocyte Count Cyclopropanes Double-Blind Method Drug Therapy, Combination Female HIV-1 HIV Infections Humans Indinavir Male Middle Aged Oxazines Reverse Transcriptase Inhibitors RNA, Viral Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: